Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2018

Aug 13, 2018

SELL
$13.3 - $17.45 $3.95 Million - $5.18 Million
-296,900 Closed
0 $0
Q1 2018

May 25, 2018

SELL
$14.7 - $24.95 $432 Million - $733 Million
-29,393,100 Reduced 99.0%
296,900 $826,000
Q1 2018

May 11, 2018

BUY
$14.7 - $24.95 $434 Million - $736 Million
29,495,300 Added 15149.1%
29,690,000 $826,000
Q4 2017

Feb 14, 2018

BUY
$19.9 - $29.25 $3.87 Million - $5.69 Million
194,700 New
194,700 $537,000
Q4 2017

Feb 01, 2018

SELL
$19.9 - $29.25 $861,669 - $1.27 Million
-43,300 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$15.1 - $19.25 $653,830 - $833,525
43,300
43,300 $43,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.